Cargando…

Factors contributing to clinical picture and progression of Huntington's disease

Detalles Bibliográficos
Autor principal:	Zielonka, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108195/ https://www.ncbi.nlm.nih.gov/pubmed/30106046 http://dx.doi.org/10.4103/1673-5374.235241

Ejemplares similares

Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
por: Mantuano, Elide, et al.
Publicado: (2019)

Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease
por: Xie, Jiahua, et al.
Publicado: (2023)

Striving for a Realistic and Unapologetic View of Huntington’s Disease
por: Serbin, Kenneth P.
Publicado: (2022)

Skeletal muscle pathology in Huntington's disease
por: Zielonka, Daniel, et al.
Publicado: (2014)

Histone methylation in Huntington’s disease: are bivalent promoters the critical targets?
por: Zsindely, Nóra, et al.
Publicado: (2018)

Putting the Brakes on Huntington Disease in a Mouse Experimental Model
por: Kim, Jane C., et al.
Publicado: (2015)

Hopping from One Cell to Another: Huntington's Disease Propagates
por: Park, Sang Myun
Publicado: (2017)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

Excitatory synapse impairment and mitochondrial dysfunction in Huntington’s disease: heat shock factor 1 (HSF1) converging mechanisms
por: Zarate, Nicole, et al.
Publicado: (2019)

Therapeutic potential of insulin-like growth factor 2 in Huntington’s disease: controlling proteostasis to alleviate the load of misfolded protein
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2021)

Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease
por: Zielonka, Daniel, et al.
Publicado: (2020)

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

To Sleep to Dream … No More? The Quest for Restorative Sleep in Huntington’s Disease, a Clinician’s Perspective
por: Rosas, Herminia Diana
Publicado: (2023)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
por: Rocha, Natalia P., et al.
Publicado: (2018)

Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington’s disease
por: Grice, Stuart J., et al.
Publicado: (2023)

The Bionic Radiologist: avoiding blurry pictures and providing greater insights
por: Dewey, Marc, et al.
Publicado: (2019)

Structural Abnormalities of the Optic Nerve and Retina in Huntington’s Disease Pre-Clinical and Clinical Settings
por: Mazur-Michałek, Iwona, et al.
Publicado: (2022)

Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations
por: Fatima, Azra, et al.
Publicado: (2019)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Black Salve (or escharotics). A picture about an unorthodox medical preparation in oncology
por: Borkens, Yannick
Publicado: (2023)

Climate communication for biologists: When a picture can tell a thousand words
por: Lewandowsky, Stephan, et al.
Publicado: (2018)

Gene therapy for Parkinson's disease: a decade of progress supported by posthumous contributions from volunteer subjects
por: Bartus, Raymond T.
Publicado: (2015)

Multiple pathways contribute to the pathogenesis of Huntington disease
por: Li, Shihua, et al.
Publicado: (2006)

A picture of severe COVID-19 in US children and youth emerges
por: Long, Sarah S.
Publicado: (2020)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

A Picture Worth a Thousand Words, Created with One Sentence: Using Artificial Intelligence–created Art to Enhance Medical Education
por: Huston, John C., et al.
Publicado: (2023)

Post-COVID-19 Fatigue: Potential Contributing Factors
por: Rudroff, Thorsten, et al.
Publicado: (2020)

The Axis of Progression of Disease
por: Tartakoff, Alan M, et al.
Publicado: (2014)

Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland
por: Zielonka, Daniel, et al.
Publicado: (2020)

Potential Factors That Contribute to Post-COVID-19 Fatigue in Women
por: Rudroff, Thorsten, et al.
Publicado: (2022)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Cognitive Dysfunction Contributes to Mobility Impairments in Huntington’s Disease
por: Kloos, Anne D., et al.
Publicado: (2017)

Identification of contributing genes of Huntington’s disease by machine learning
por: Cheng, Jack, et al.
Publicado: (2020)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
por: Wainberg, Michael, et al.
Publicado: (2021)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Donor genetic backgrounds contribute to the functional heterogeneity of stem cells and clinical outcomes
por: Wang, Ting, et al.
Publicado: (2020)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)

Activation of tyrosine phosphatases in the progression of Alzheimer's disease
por: Stewart, Alexandre F. R., et al.
Publicado: (2020)

Olden’s Contributions
por: Nussbaum, Rudi H.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_0psetid7i563im4t4js5nn2ifd